Merger Notification - Announcement according to § 10 Cartel Act
Watling XIX, SCSp; Saratoga SPV, LLC; Red Lion 601, SCSp; Red Lion U.S., LP; Ardi TopCo Ltd.; Montagu Private Equity LLP
BWB/Z-7526
On 23.10.2026 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Watling XIX, SCSp, Saratoga SPV, LLC, Red Lion 601, SCSp and Red Lion U.S., LP (Luxembourg/USA), which are indirectly owned by funds or vehicles advised or managed by affiliates of CVC Capital Partners plc (Jersey), intend to acquire a limited partnership interest of more than 50% as lead investors in a continuation fund established, and managed and/or advised, by affiliates of Montagu Private Equity LLP (United Kingdom), which will then acquire Ardi TopCo
Ltd. (operating under the brand name Evergen) (USA) from another fund managed and/or advised by Montagu.
The concentration concerns the development, manufacture and supply of allograft and xenograft biomaterials used in regenerative medicine.
Affected industry: Manufacture of pharmaceutical preparations.
C - MANUFACTURING C 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations, C 21.2 - Manufacture of pharmaceutical preparations, C 21.20 - Manufacture of pharmaceutical preparations
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 20.11.2026.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.